Latest Event Updates
A new report by Allied Market Research titled, “Global Oncology/Cancer Drugs Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020“, forecasts the market to reach $111.9 billion by 2020, registering a CAGR of 7.1% from 2014 to 2020. Increase in adoption of combination therapies instead of traditional cytotoxic therapies is a major factor that contributes to the market growth. The combinational therapies which includes targeted therapy and immunotherapy (Biologics therapy), is expected to witness ~10% surge in its market share collectively by 2020.
Augmentation in the prevalence and incidence rate of various cancers, growing popularity of biological and targeted modalities, along with the patent expiration of major cancer drugs are expected to drive the growth of global oncology drugs market. However, high initial capital investment for new drug development, long-term side effects associated with chemotherapy, and high cost of advanced therapies (targeted and immunotherapies) would limit the growth of the market.
To view the report, visit the website at http://www.alliedmarketresearch.com/oncology-cancer-drugs-market
The global oncology drugs market is experiencing a shift in therapeutic modalities i.e. from traditional cytotoxic agents to newly develop targeted and immunotherapeutic modalities. Tumor cell specificity, an attribute of aforementioned modality, has reduced drug remission rates and has rendered an enhanced rate of survival in cancer patients thus, complementing the market growth. However, chemotherapeutic modalities would continue to be the leading therapeutic modality segment owing to its higher adoption rate and economic pricing. Going forward, the demand for the chemotherapy modality might confront a negative influence due to marginal efficacy and chronic side effects such as anemia.
Geographically, the developed economies such as North America and Europe collectively accounted for ~65% of market share in 2014, due to higher adoption rates and advanced hospital settings. However, developing economies are expected to experience potential opportunities owing to the emergence of biosimilars in monoclonal antibodies, and improved medical infrastructure.
Key Findings of the Study:
- Immunotherapy/biological drugs segment expected to grow at a double digit CAGR during the forecast period and would grow at the fastest rate
- Blood cancer is the major revenue generating segment in the global oncology drug application market however, lung cancer segment is expected to grow fastest among all
- Currently, North America garners a major share in the oncology drugs market, in terms of market size
- Asia Pacific oncology drug market is dominated by China and Japan, together contributing to ~60% of the regional market revenue in 2014
A majority of the oncology drug manufacturers have adopted collaboration and acquisition as key developmental strategies to achieve a competitive edge. Moreover, companies are also forming strategic alliances to accelerate the process of clinical trials. These strategies have proved to be effective in helping key market players retain their leading positions in the global oncology drugs market. Key companies profiled in the report are Roche diagnostics, Novartis AG, Celgene Corporation, AstraZeneca, Johnson & Johnson, Merck & Co., Eli Lilly & Co., Amgen Inc., Pfizer and GlaxoSmithKline.
Global Hernia Repair Devices and Consumables Market is Expected to Reach $6.1 Billion, Globally, by 2020 – Allied Market Research
A new report by Allied Market Research titled, “Global Hernia Repair Devices and Consumables Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 –2020“, forecasts the market to grow at a CAGR of 6.5% during 2014 – 2020. Consumables (mesh, staple and tacks) segment would continue to be the leading segment of the global hernia repair market in 2020, largely due to the augmentation in hernia cases, recurrence rate and emergence of advanced meshes.
Increase in number of hernia repair surgeries (laparoscopy and open tension-free repair) would be the prime factor responsible for the market growth during the forecast period. As per AMR analysis, total number of hernia repair surgery was ~27 million in 2013 and is expected to reach ~36 million by 2020. Furthermore, other factors driving the market include emergence of novel meshes, technologically advanced hernia fixation devices and growing obese population. However, lack of adequate reimbursement policies and high cost associated with hernia repair procedures would restrain the market growth to a certain extent.
To view the report, visit the website at http://www.alliedmarketresearch.com/hernia-repair-devices-market
Healthcare professionals still prefer synthetic mesh for hernia repair surgeries despite of chronic pain associated with it. However, biological meshes would be the ultimate choice for patient with high risk. Popularity of synthetic mesh is largely due to the attributes such as cost effectiveness, lesser risk of infection (less than 3%) and hard-wearing (remain permanently in the body). In case of biological mesh, it has few limitations such as risk of infection and less stronger as compared to synthetic mesh. Ongoing improvements in meshes such as absorbable, non-absorbable or partially absorbable is also a significant factor fuelling the consumables market.
Inguinal hernia is most prevalent type of hernia across the world and hence accounted for about 3/4th of the hernia repair market revenue in 2014. Geographically, North America and Europe, collectively contribute ~75% of the market share in 2013 due to increasing adoption of laparoscopic surgery and rising incidences of hernia. Asia-Pacific and LAMEA market is posed to grow at a significant pace due to increasing awareness and rising per capita expenditure on healthcare.
Key findings of the study:
- Consumables segment is most attractive segment with faster growth and higher revenue share within hernia repair market
- North America will remain the leading region through 2020, closely followed by Europe
- Incisional Hernia is expected to be the fastest growing market segment during the forecast period
Key product manufacturing companies profiled in the report include Medtronic (Covidien), Ethicon, Davol, Cooper Surgicals, Cook Medicals, LifeCell Corporation, Insightra medical, B Braun Melsungen, W. L. Gore Inc. and Baxter Inc.
Small Animal Imaging (In-Vivo) Market is Expected to Reach $2.1 Billion, Globally, by 2020 – Allied Market Research
A new report by Allied Market Research titled, “Global Small Animal Imaging (In-Vivo) Market (Technology, Application and Geography) – Size, Share, Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020”, forecasts the market to grow at a CAGR of 9.1% from 2014 to 2020. Optical imaging modality is and would continue to be the most preferred imaging technology for clinical research organizations (CROs) through 2020, largely due to high sensitivity, economic pricing and a broad scope of applications. Such factors would eventually push the optical imaging technology segment to contribute about 40% of the global small animal imaging market revenue by 2020.
To view the report, visit the website at http://www.alliedmarketresearch.com/small-animal-imaging-market
Rising number of pre-clinical research, increasing investments by the CROs in the research activities, growing number of multi-functional pre-clinical imaging and technological advancements, namely combination of high resolution MRI with other imaging modalities are the few factors empowering the global market. Spatial resolution multimodal imaging, Cerenkov Bioluminescence Imaging and real time storage multimodal imaging system collectively contribute to the significance of small animal imaging (in-vivo) systems in the drug development and translational research. These technologies exemplify the recent and unique advancements in the field of diagnostic devices, amplifying the scope of applications in pre-clinical as well as clinical research. However, stringent regulatory impositions coupled with inadequate reimbursement policies would restrain the market growth to a certain extent. However, faster commercialization of cost-efficient devices would ease the negative influence of restraints and fuel the market growth, primarily across the developing regions.
Most common small animal in-vivo imaging devices used in pre-clinical applications are micro-MRI, optical imaging, and nuclear imaging modalities, namely as the micro-PET and micro-SPECT, micro-ultrasound, micro-CT and optical imaging. Owing to the versatility of imaging modalities, they are used in a variety of biomedical applications such as monitoring treatment responses, assessing bio-distribution patterns, cancer cell detection, and longitudinal as well as epigenetic studies. Routine application of imaging in bio-distribution and drug monitoring together contributed to ~60% of the market in 2013. Existing potential growth opportunities in oncological research would make the cancer cell detection application market lucrative and thus, would emerge as a fastest growing application market segment during the forecast period.
Geographically, ~67% of the small animal imaging (in-vivo) market share is held by the developed regions, due to heavy investments and affordability of advanced small animal in-vivo imaging devices. North America is the dominant region owing to its adoption of advanced technologies, healthcare awareness and favorable reimbursement policies. The research outcomes in the field of small animal imaging market in North America are the blend of academic and industry efforts supported by government programs and initiatives.
Key findings of the study:
- Micro MRI, nuclear imaging, and micro CT modalities collectively accounted for about 52% of the revenue generated in 2013
- Optical imaging and micro-MRI technology segments would collectively command over 2/3rd of the market revenue during the forecast period
- Cancer cell detection application market segment would grow at a highest rate during the forecast period, owing to the rising prevalence rate of cancer across the world
Technologies have a notable impact on the global small animal imaging market and manufacturers with novel technology rights are holding substantial market share. Advent in these novel technologies lead to launch of new and advance product lines in small animal imaging market. To gain the maximum market share, key leaders of the small animal in-vivo imaging market have adopted acquisition as a strategy, which has proved to be the most successful for this market. Key companies profiled in this report are, Thermo Fisher Scientific, Siemens AG, Mediso Medical Imaging Systems, Life Technologies Corporation, Promega Corporation, Miltenyi Biotech, Bruker Corporation, FujiFilm Holding Corporation, PerkinElmer Inc., and Aspect Imaging Ltd.
Global Encryption Software Market is Expected to Reach $2.16 Billion by 2020 – Allied Market Research
According to a new report by Allied Market Research titled, “Global Encryption Software Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020“, the global encryption software market is expected to reach $2.16 billion by 2020, registering a CAGR of 14.27% during 2014 – 2020. Software based encryption is gaining prominence as one of the end point security solutions, as it is increasingly being adopted by the organizations worldwide. With data protection and data privacy compliance becoming a high priority, organizations have started viewing encryption as an enabler to achieve compliance and data security and at the same time mitigate the data breach risks associated with the adoption of advanced technologies, particularly cloud services and mobility.
To view the report, visit the website at http://www.alliedmarketresearch.com/encryption-software-market
From the application perspective, encryption is used across all the industries to secure both data-at-rest (data stored in data stored in files/folders and disks); and data-in-transit (email messages travelling over the network). The adoption of software-based encryption for protecting data-at-rest is higher as compared to the adoption of the same for data-in-transit. Data-at-rest encryption software accounts for approx. 93.5% of the total encryption software market by value. For data-at-rest, the two most commonly used encryption software methods include Full Disk Encryption (FDE) and File Level Encryption (FLE), with Full Disk Encryption software being the most widely deployed method for protecting data against theft and ensuring compliance with the data privacy and data breach notification laws. Full Disk Encryption is preferred over the File Level Encryption, primarily due to the two major advantages such as ease of deployment and management and complete security.
Presently, software based encryption enjoys the highest adoption in the Financial Services sector with a growing acceptance in the Healthcare Sector. Financial sector accounts for approximately 44% of global encryption software market amongst all the other industries. Entities operating in the sector are mandated by the data privacy regulations to adopt effective security measures in their organization and need to ensure that the personally identifiable data (PII) of the customers is protected from any unauthorized or unintended disclosure/access.
Key findings of the study:
- Presently, Encryption software for Data-at-Rest accounts for the major share of the encryption software market as compared to the encryption software for data-in-transit (email)
- Within the Data-at-rest encryption software market, Software- based Full Disk Encryption (FDE) holds the majority share vis-à-vis File Level Encryption (FLE), with FDE expected to be the more widely adopted technology in 2020
- Based on the geographic analysis, North America presently is and would continue to be the highest revenue-generating region, throughout 2014 – 2020. However, the growth would be higher in the developing regions particularly APAC
- The use of Encryption software is most widespread in the Finance Sector, which is presently largest contributor i.e. approx. 44% to the total Encryption Software Revenue
- The adoption of encryption software is higher amongst large enterprises compared to the small and medium sized businesses
The evolving data protection regulatory landscape, burgeoning number of data breaches coupled with the increasing adoption of technologies particularly cloud are driving the adoption of encryption software worldwide. A large number of organisations are adopting an enterprise wide encryption strategy plan rather than informal policies. With the rapidly increasing adoption of cloud services in all the sectors, the organisations are now looking at encryption solutions that would ensure data security and compliance with the data privacy regulations for their data in the cloud. Furthermore, the highest interest will be in encryption solutions from cloud security vendors.
Photonic Sensors Market is Expected to Reach $15.2 Billion, Globally, by 2020- Allied Market Research
According to a new report by Allied Market Research, titled “Global Photonic Sensors Market (Type, Technology, Application and Geography) – Global Opportunity Analysis and Forecast – 2013 – 2020″, the global photonic sensor market is forecast to reach $15.2 Billion by 2020, growing at a CAGR of 16.9% during the period (2014 – 2020). The study confers the dominance of fiber optic sensors and sheds light on the way, biophotonic sensor would garner more market share during the forecast period. Based on its application, biophotonic technology is expected to be the fastest growing technology in the photonic sensor market. Military is expected to be the largest revenue-generating segment till 2019, due to the wide-ranging applications of photonic sensors in various defense equipment. Geographically, North American region is leading and it would maintain the lead throughout the forecast period.
To view the report, visit the website at http://www.alliedmarketresearch.com/photonics-sensor-market
Need for enhanced safety and security solutions, better alternative for conventional technology and rise in wireless sensing technology would act as the major factors responsible for driving the photonic sensor market. The U.S. army’s adoption of photonic technology on a large scale for various applications has led the military segment to capture substantial market share in the photonics sensors market. The U.S. Army Research Laboratory’s Sensors and Electron Devices Directorate (SEDD) is responsible for development in the field of electronic devices, sensors and power & energy. Based on the continuous research, SEDD has developed electro-optic and photonic devices, which include active and passive sensors. Asia-Pacific is expected to be the fastest growing region in the global photonic sensors market, with Japan being the leader in the development of advanced photonic technology.
The photonic sensors are used in multiple applications, as these devices have the capability to provide accurate cost effective image sensing solutions as compared to the conventional sensors. Based on the wide scale application of photonic technology in military programs, this segment is estimated to generate substantial revenue during the forecast period. Industrial processes would have the next highest revenue share followed by biomedical applications. The Homeland security and oil & gas applications are expected to have the highest growth rate compared to other applications of photonic sensors.
Currently, fiber optics is the most commonly used technology in sensing applications, as it is well established and possess strong sensing capabilities. Numerous organizations across the globe offer fiber optic sensors that can withstand harsh environmental conditions such as extreme heat, noise, corrosion, explosion and vibration. Fiber optic sensors are compact in size and light in weight, which make them ideal for accomplishing various tasks.
Key findings of the study:
- Fiber optic and biophotonic will be the most popular sensors in the photonic sensor market
- Fiber optic technology would continue to lead the photonic sensor market through 2020
- Military is the highest revenue generating market in the application segment, which is estimated to be surpassed by the industrial process market by 2020
- Oil and gas industry is expected to be the fastest growing application segment in the photonic sensor market
Baumer Holdings AG, Banner Engineering Corp., Omron Corporation, Hamamatsu Photonics KK and Truesense Imaging Inc. are some of the major companies that are profiled in the report. Product launch and acquisition are the prime corporate strategies adopted by these companies. In November 2014, Hamamatsu Photonics KK announced the launch of an energy discriminating radiation line sensor. This sensor consists of direct conversion type semiconductor, which is used to inspect the thickness of wall of a pipe.
According to a new report by Allied Market Research titled, “Global E-Waste Management Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020“, the global E-Waste Management Market would reach an amount of $49.4 billionby 2020, registering a CAGR of 23.5% during 2014 – 2020. The ever-growing need for adapting the latest technology is the prime factor for a large volume of E-Waste generated across the globe. The Asia Pacific region contributes to the largest revenue share in the global E-Waste management market, followed by European countries. Analysis of the market indicates that the global volume of E-waste accounted for 57.7 million tons in 2013.
To view the report, visit the website at http://www.alliedmarketresearch.com/e-waste-management-market
StEP (Solving the E-waste problem) is a German based establishment that manages the processing of E-Waste in developed countries. Ruediger Kuehr, executive secretary of StEP, states that Rapid product innovations and replacements for electronic gadgets account for the rise in E-Waste worldwide. The monumental rise of E-Waste brings across an impending need for all countries to manage their E-Waste effectively. The U.S. is a major exporter of used electronic goods. The region exports a large quantity of CRT (cathode ray tubes) monitors and a considerable number of cellphones, amongst other electronic devices. National Center for Electronics Recycling (NCER), is a U.S. based non-profit organization dedicated to the enhancement of national infrastructure for recycling E-waste. NCER states that, nearly 54 million tons (49 metric million tons) of E-Waste, i.e. approximately 43 lbs (20kg) per person, is generated every year across the globe. The study estimates that U.S. generates a large quantity of E-waste, major portion of which is shipped to developing countries (mainly Asia) and West Africa, where it is usually disposed-off in backyards or recycled. These deposits ultimately cause numerous health issues and environmental hazards.
Jason Linnell, an Executive director of NCER has mentioned that the U.S is yet to fully utilize its recycling capacity as compared to other countries. Presently, North America is largely taking initiatives to recycle its E-Waste. The StEP estimated that the U.S generated about 258.2 million units of used-electronics (monitors, cellphones, computers and TV sets) in 2010, of which, 171.4 million were collected for recycling and 14.4 million were exported. The E-Waste management initiatives in North America should significantly reduce E-waste exports and propel the domestic market. Adoption of E-Waste management programs by all the countries globally, would further minimize the health concerns and significantly reduce environmental hazards. Presently, North America is a leader in exporting E-Waste to developing countries. These exports generate a large quantity of trash for recycling in emerging markets. TheAsia-Pacific comparatively generates a larger revenue from the recycled E-Waste. However, North America is also in the process of recycling the E-waste, which would add to a larger share of its revenue in the global market.
From the year 2000 – 2005, the Organization for Economic Co-operation and Development (OECD), identified a growth of approximately 22% in Information and Communications Technology (ICT) market in China, declaring it to be the 6th largest ICT market in 2006, followed by the U.S, Japan, Germany, UK and France. Thus, in the wake of constant innovation and rapidly increasing adoption of new technologies, there exists a need more than ever before, for the adoption of E-Waste management programs, globally.
Key findings of the study:
- Presently, the trashed E-waste holds a larger percentage share as compared to the recycled E-Waste.
- In the global E-Waste management market, household appliances generate the largest amount i.e. approx. 46% of E-Waste as compared to other sources, followed by the IT and Telecommunications sector
- The IT and Telecommunications sector is expected to produce a large volume of E-Waste by 2020
- Asia-Pacific region would generate the highest revenue for the E-Waste management market by 2020.
- The E-Waste management rate in Asia-Pacific and European regions is higher than developed countries such as U.S, Canadaand Mexico
Human health concerns and environmental hazards caused due to E-Waste production, annually, are leading to the rise of E-Waste management programs all over the world. The government agencies with the help of E-waste management players, are strategically focusing on new and innovative E-Waste Management programs. These programs are focused at reducing the world’s E-Waste and its hazards. Lack of awareness regarding the hazards associated with E-Waste in the LAMEA region and the lack of E-Waste recycling plants in the United States, support the growth of the global E-Waste management market, at a faster pace. The key providers of recycling services, profiled in this report are Stena Metall AB, SIMS Recycling Solutions, Umnicore, Electronic Recyclers International Incorporation, Tetronics Limited, CRT Recycling Incorporation, LifeSpan Technology Recycling Incorporation, Triple M Metal LP, MBA Polymers Incorporation and Enviro-Hub Holdings Limited.
Global Erythropoietin Drugs Market is Expected to Reach $11.9 Billion by 2020 – Allied Market Research
A new report by Allied Market Research titled, “Global Erythropoietin (EPO) Drugs Market (Type, Application and Geography) – Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013-2020”, forecasts the Global EPO market to reach $11.9 billion by 2020, with promising CAGR of 9.7% from 2014 to 2020. Darbepoetin alfa is fastest growing drug class at a CAGR of 12.9% during the forecast period, owing to its high potency and minimal side-effects.
Rising incidences of Cancer, ESRD (End Stage Renal Disease), and HIV have largely contributed to the overwhelming demand for EPO drugs. Approximately 20% of the patients suffering from Cancer/HIV and ~70% of the patients suffering from ESRD undergo chemotherapy, which induces anemia in such patients, requiring EPO treatment. Despite this, the market nevertheless witnesses restraints due to highly priced EPO drugs resulting in minimal adoption. However, commercialization of EPO biosimilars would eventually ease the influence of restraints and fuel the market growth, primarily across the developing regions.
To view the report, visit the website at http://www.alliedmarketresearch.com/erythropoietin-market
Globally, ~70% of the market share is held by the developed regions owing to favorable reimbursements leading to affordability for EPO drugs. Going forward, owing to commercialization of EPO biosimilars, the Asia-Pacific EPO drugs market would be the most potential market among other regions.
Key findings of the study:
- Europe led the global EPO drug market in 2013 closely followed by North America
- Asia Pacific EPO drugs market is projected to grow at a CAGR of 13.3% during the forecast period, fastest among the four geographies
- Currently, Anemia therapeutics (Cancer and HIV treatment) market leads the overall EPO drugs market; however, kidney therapeutic segment would emerge as the largest market segment by 2020
- Originator companies are investing in R&D for expanding product i.e. EPO drug applications to newer disorders such as neural diseases and in wound healing
- EPO drugs market is witnessing high commercialization of biosimilars for the ‘off-patent’ drug namely Erythropoietin alfa
The first EPO drug – Epogen (Erythropoietin alfa), launched by Amgen, has witnessed patent expiry in 2014. Following this, a number of biosimilar Erythropoietin alfa have been launched by major companies such as Biocon, Ranbaxy, Emcure Pharmaceuticals. In addition, Amgen currently owns the patent Aranesp for Darbepoetin alfa; which is expected to expire by 2016, thus, calling for launch of Darbepoetin alfa biosimilars. Some of leading players operating in EPO drug market are Amgen Inc., Johnson & Johnson, Roche, LG Life Sciences Ltd., Biocon, Intas Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Celltrion, Inc.